Health Condition 1: N719- Inflammatory disease of uterus, unspecified Health Condition 2: N719- Inflammatory disease of uterus, unspecified
Conditions
Interventions
Intervention1: Rasagandhimezhugu: 500mg twice a day After food with palmjaggery for 45 days,followed by drug holiday 15 days .Again repeated for 45 days.
Control Intervention1: nil: not applicable
Sponsors
Central Council for research in Siddha
Eligibility
Inclusion criteria
Inclusion criteria: fibroid size 1 to 8cm,irrespective location of fibroid Presence of fibroid confirmed by Ultrasonogram Symptomatic and Asymptomatic patientswill be included Ambulatory and co-operative Willing to give consent to participate in the trial
Exclusion criteria
Exclusion criteria: Any previous surgical intervention underwent for fibroid subjects with cervical malignancy diagnosed with papsmear Subjects with known malignancy in any part of the body Metabolic disorders like Diabetes,Liver disorders,chronic liver conditions like Liver failure,Renal failure,jaundice etc., Vulnerable patients like HIV Pregnancy,Lactating mothers,Planning for pregnancy Not willing to give consent to participate in the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of size of fibroid and changes in clinical symptom from the baselineTimepoint: at baseline,at the end of 3rd month and at the end of 9th month | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects, drug compliance, recurrence of fibroidTimepoint: From the baseline,at the end of three months and at the end of 9 months. | — |
Countries
India
Contacts
Public ContactShyamala Rajkumar
Siddha Central Research Institute
Outcome results
None listed